Faraday Pharmaceuticals

faradaypharma.com

Faraday Pharmaceuticals developed iodide-based therapies for medical applications and conducted clinical trials in STEMI patients.

Facts

HQ
Seattle, Washington, US
Sectors
Pharmaceutical Manufacturing
Founded
2014
Type
Corporation Seattle business license
Employees
11–50
Registered name
Faraday Pharmaceuticals Seattle business license
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Faraday Pharmaceuticals

See all 4

Proniras launches in Seattle to develop Eli Lilly’s tezampanel, wins $89.5M BARDA contract

Proniras Corporation launched in Seattle to develop tezampanel, a seizure drug originally created by Eli Lilly, and secured an $89.5 million BARDA contract contingent on development milestones. The company also received undisclosed launch funding from several investors, will be led by co-founder and CSO Chris Toombs, and plans to explore tezampanel as both a seizure therapy and a nerve-agent antidote.

Online

Questions about Faraday Pharmaceuticals

What is Faraday Pharmaceuticals?

Faraday Pharmaceuticals is a former startup based in Seattle, Washington, US, that developed iodide-based therapies for medical applications and conducted clinical trials in STEMI patients.

What has Faraday Pharmaceuticals been in the news for?

GeekWire reported in September 2019 that Faraday Pharmaceuticals was a Fred Hutch spinout advancing an iodide drug to prevent reperfusion injury and muscle loss.

Who invested in Faraday Pharmaceuticals, and how much has it raised?

Members of Seattle Flow see Faraday Pharmaceuticals' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Faraday Pharmaceuticals based?

Faraday Pharmaceuticals is based in Seattle, Washington, US.

When was Faraday Pharmaceuticals founded?

Faraday Pharmaceuticals was founded in 2014.

How many people work at Faraday Pharmaceuticals?

Faraday Pharmaceuticals has 11–50 employees.